- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 40/15 - Natural-killer [NK] cellsNatural-killer T [NKT] cells
Patent holdings for IPC class A61K 40/15
Total number of patents in this class: 630
10-year publication summary
|
7
|
7
|
12
|
23
|
41
|
54
|
29
|
15
|
190
|
173
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immunitybio, Inc. | 507 |
38 |
| Board of Regents, The University of Texas System | 6107 |
21 |
| Nkarta, Inc. | 78 |
18 |
| Takeda Pharmaceutical Company Limited | 2712 |
15 |
| GC Cell Corporation | 60 |
15 |
| The Regents of the University of California | 20745 |
11 |
| Research Institute at Nationwide Children's Hospital | 638 |
10 |
| FATE Therapeutics, Inc. | 235 |
9 |
| Memorial Sloan-Kettering Cancer Center | 2043 |
9 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 1021 |
8 |
| Indapta Therapeutics Inc. | 22 |
8 |
| Dana-Farber Cancer Institute, Inc. | 2664 |
7 |
| Imperial College Innovations Limited | 683 |
7 |
| National University of Singapore | 2583 |
7 |
| Sloan-Kettering Institute for Cancer Research | 614 |
7 |
| Nantcell, Inc. | 151 |
7 |
| Memorial Hospital for Cancer and Allied Diseases | 403 |
7 |
| Artiva Biotherapeutics, Inc. | 35 |
7 |
| The Board of Trustees of the Leland Stanford Junior University | 6653 |
6 |
| University of Central Florida Research Foundation, Inc. | 1248 |
6 |
| Other owners | 407 |